Oral poliovirus vaccine in management of recurrent aphthous stomatitis

Acta Microbiologica et Immunologica Hungarica

Volumn 55, Issue 3, 2008, Pages 343-350

  Yazdanpanah, M J ^a   Mokhtari, Mojgan Bayat ^b   Mostofi, K ^a   Soleimani, M ^a   Ebrahimirad, M ^a   Esmaili, H ^a   Ahmadi, Sara Nedaei ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Aphthous; Oral polio vaccine; Stomatitis

Indexed keywords

HERPES; POLIOVIRUS;

EID: 51049113204     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.55.2008.3.5     Document Type: Article

References (16)

1. th edition. Mc Graw-Hill, New York, pp. 1301-1348 (1999).
2. st edition, Saunders, Philadelphia, pp. 1330-1331 (1996).
3. Rogers, R. S.: Recurrent aphthous stomatitis: Clinical characteristics and associated systemic disorders. Semin Cutan Med Surg 16, 278-283 (1997).
4. th edition, Lippincott Williams Wilkins, Philadelphia, pp. 26-31 (2002).
5. Plesnik, V., Machalek, J.: Prevention of recurrence of herpes with poliovaccine. Epidemiol Microbiol Immunol 49, 103-109 (2000).
6. Garrel, J., Millet, P., Sonneck, J. M., Grossetete, G., Tilles, G.: Recurrent herpes: treatment using trivalent oral poliovaccine. Nouv presse Med 8, 47 (1979).
7. Riggio, M. P., Lennon, A., Ghodratnama, F., Wray, D.: Lack of association between streptococcus oralis and recurrent aphthous stomatitis. J Oral Pathol Med 29, 26-32 (2000).
8. Katz, J., Chaushu, G., Peretz, B.: Recurrent oral ulceration associated with recurrent herpes labialis - two distinct entities? Community Dent Oral Epidemiol 29, 260-263 (2001).
9. Pedersen, A.: Acyclovir in the preventation of sever aphthous ulcers. Arch Dermatol 128, 119-120 (1992).
10. Sabin, A. B.: Properties and behavior of orally administered attenuated poliovirus vaccine. J Am Med Assoc 164, 1216-1223 (1957).
11. Xiang, X., Liu, J., Li, H.: Cytomegalovirus infection and the changes of T-lymphocyte subsets in RAU patients. Zhonghua Kou Qiang Yi Xue Za Zhi 35, 212-214 (2000).
12. Sistig, S., Cekic-Arambasin, A., Rabatic, S., Vucicevic-Boras, V., Kleinheinz, J., Piffko, J.: Natural immunity in recurrent aphthous ulceration. J Oral Pathol Med 30, 275-280 (2001).
13. Guranska, N., Lewkowicz, P., Urbaniak, B., Banasik, M., Gowacka, E., Lauk-Puchaa, B., Peterson, R., Tchórzewski, H.: The assessment of effectiveness of the shark liver oil in RAS treatment: clinical and immunological studies. Pol Merkur Lekarski 11, 233-238 (2001).
14. Brozovic, S., Vucicevic-Boras, V., Mravak-Stipetic, M., Jukic, S., Kleinheinz, J., Lukac, J.: Salivary levels of vascular endothelial growth factor (VEGF) in recurrent aphthous ulceration. J Oral Pathol Med 31, 106-108 (2002).
15. Palmer, P., Charley, B., Rombaut, B., Daron, M., Lebon, P.: Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II fcgamma receptor (CD32). Virology 278, 86-94 (2000).
16. th edition. Saunders, Philadelphia, pp. 1036-1042 (2004).